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Boyse and co-workers have identified several systems of murine isoantigens 
called Ly antigens (for lymphocyte antigens) (e.g. Ly-1, Ly-2, Ly-3, and Ly-5) 
which appear to be restricted to thymic lymphocytes and peripheral T lympho- 
cytes (1-3). Each system, defined by cytotoxic alloantisera, appears to be deter- 
mined by a genetic locus which contains two alternative alleles (e.g., Ly-2 a and 
Ly-2 b) governing expression of two alternative cell surface antigenic specificities 
(e.g. Ly-2.1 and Ly-2.2, respectively). TheLy-1 locus has been shown to reside in 
linkage group XII (4), and the Ly-2 and Ly-3 loci are extremely closely linked to 
each other in linkage group XI of the mouse (5). 
Using the antibody-blocking test  (6), Boyse and co-workers have obtained 
evidence that the Ly-2 and Ly-3 antigenic determinants are topologically in 
close proximity on the cell surface. The close genetic and topological linkage of 
Ly-2 and Ly-3 have prompted Itakura et al.  (5) to suggest that Ly-2 and Ly-3 
may actually comprise a single complex locus, Ly-2,3, and that their respective 
antigenic determinants may reside upon a single molecule. 
Although the functions of the molecules bearing the Ly antigenic specificities 
(hereafter referred to as the Ly antigens) are unknown, recent evidence using 
the C57BL/6 inbred strain (phenotype Ly-1.2, Ly-2.2, and Ly-3.2) suggests that 
different functional subclasses of peripheral T lymphocytes may bear different 
sets of Ly antigens (7, 8). Peripheral T cells bearing only the Ly-l.2 specificity 
appear to perform a  helper function in the humoral and perhaps the cellular 
immune response. Killer cells or their precursors and suppressor T cells appear 
to bear both the Ly-2.2 and Ly-3.2 specificities but not Ly-l.2. The majority of 
peripheral T-cells appear to bear all three specificities (Ly-l.2, Ly-2.2, and Ly- 
3.2)  and may be precursors of the functional subclasses bearing a  restricted 
selection of Ly antigens. 
A genetic marker in the V region of mouse immunoglobulin L chains (called 
the I~-peptide marker) (9) has been demonstrated to be very closely linked to the 
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Ly-2 and Ly-3 genetic loci in linkage group XI (10, 11). In inbred and congenic 
strains, complete correlation was observed between expression of this V-region 
marker on approximately 5% of normal serum IgG L chains and expression of 
the Ly-3.1 surface antigenic specificity on thymic lymphocytes. The close genetic 
linkage of a VL-region polymorphism with a thymic lymphocyte surface antigen 
which may be determined by a  complex genetic locus raised the question of 
whether the molecules bearing the Ly-3.1 antigenic specificity might contain L 
chains or L-chain V regions. 
Techniques involving radiolabeling of cell surface components, dissociation of 
the plasma membrane with detergents, precipitation with specific alloantisera, 
and analysis by sodium dodecyl sulfate (SDS)l-polyacrylamide gel electrophore- 
sis (PAGE) have been used to determine the approximate molecular weights of 
polypeptide chains comprising a large number of cell surface antigens (12-18). 
We have used such methods to characterize the polypeptides of the Ly-2 and Ly-3 
antigens present on thymic lymphocytes. 
Materials and Methods 
Mice.  C57BL/6J mice (Ly-2.2,Ly-3.2 phenotype) were obtained from The Jackson Laboratory, 
Bar Harbor, Maine. Breeding stock of the congenic C57BL/6-Ly-2a,Ly-3 ~ (Lyo2.1,Ly-3.1 pheno- 
type)  and C57BL/6-Ly-2 a (Ly-2.1,Ly-3.2 phenotype) strains were the generous gift of Dr.  E. A. 
Boyse of the Memorial Sloan-Kettering  Cancer Institute, New York, 
Antisera and IgG.  Alloantiserum specific for Ly-3.1 was produced  by successive  intraperito- 
heal injections of (CBA/H-T6J  ×  SJL/J)FI female mice with C58/J thymocytes as described by 
Boyse and c0-workers (2). Antiserum  specific for Ly-2.1 (057BL/6-H-2 ~ anti-CE/J thymocytes) was 
the gift of Dr.  E.  A.  Boyse  and Dr.  F-W. Shen, Memorial Sloan-Kettering Cancer Institute. 
Normal (CBA/H-T6J  x  SJL/J)FI and C57BL/6J sera were obtained from unimmunized female 
mice. Normal serum IgG from C57BL/6J and (CBA/H-T6J  x SJL/J)F~ mice was isolated by starch 
zone electrophoresis and two successive gel filtrations on Sephadex G-200. 
Rabbit anti-mouse IgG (RAMIG) was produced by immunization  of a New Zealand albino rabbit 
with C57BL/6J IgG. Goat anti-rabbit  IgG (GARIG) was obtained from Gateway Immunosera Co., 
Cahokia, Ill. 
Lactoperoxidase.  Lactoperoxidase  with an  A412/A2so ratio of 0.9 was purified from raw skim 
milk essentially as  described by Rombauts et  al.  (19). Aliquots were  stored  at  -70°C  at  a 
concentration of 4 mg/ml until use. 
Other Materials.  Na~25I and Na~S~I, both carrier free with an activity of 2 mCi/ml, were 
obtained from New England Nuclear, Boston,  Mass.  NaBSH4 with a specific activity of 10.5 Ci/ 
mmol was a product of Amersham]Searle Corp.,  Arlington Heights, Ill. Nonidet P-40 was pur- 
chased from Particle Data, Inc., Elmhurst, Ill. Trypsin, grade B, was obtained from Calbiochem, 
La Jolla, Calif. Soybean trypsin inhibitor, a product of Sigma Chemical Co., St. Louis, Mo., was 
kindly provided by Dr. Richard O. Hynes (MIT Center for Cancer Research).  Phosphate-buffered 
saline (PBS) consisted of NaC1, 8.0 g/liter; KC1, 0.2 g/liter; anhydrous Na~HPO4, 1.15 g/liter; 
KH2PO4, 0.2 g/liter; CaC12 dihydrate, 0.1325 g/liter; and MgCI~, 0.1 g/liter. Bovine serum albumin 
(BSA), alcohol dehydrogenase (yeast),  myoglobin (equine skeletal muscle), cytochrome  C (horse 
heart), aprotinin (trasylol) and galactose oxidase (Polyporus  circinatus,  Type 1) were obtained 
from Sigma Chemical Co. Lysozyme (egg white) was purchased from Worthington Biochemical 
Corp.,  Freehold, N. J. 
Preparation  of Thymocytes.  All procedures employing  intact thymocytes were performed in an 
ice bath or at temperatures below 7°C except for iodination and trypsinization. 
~Abbreviations  used in this paper:  BSA, bovine serum albumin; GARIG, goat anti-rabbit IgG; 
NMS,  normal mouse serum; NP-40,  Nonidet P-40; PAGE, polyacrylamide gel electrophoresis; 
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Thymocytes from 1- to 3-too-old  mice were teased into  cold  PBS (2 ml PBS/thymus). Cell 
suspensions were filtered  through 50-guage stainless  steel  mesh to  remove large  aggregates and 
were washed three  times  by centrifugation  at 140  g for  8 vain  and suspended in  i  ml of  PBS. Cell 
numbers  were  determined  in  a hemocytometer. Cell  viability  was  consistently  approximately  95% 
as determined by trypan  blue exclusion. 
Procedure  for  Iodination  of  Thymocyte Cell  Surfaces.  Thymocytes were iodinatecl  by a proce- 
dure  similar  to  that  of  Haustein  et  al.  (20).  Aliquots  containing 107  thymocytes  were  centrifuged  in 
capped  conical  polystyrene  tubes  at  140g  for  8  rain.  One  such  aliquot  of  cells  was  iodinated  for  each 
specific  or  control  precipitation  to  be  performed. Supernates  were  removed and  20 ftl  of  lactoperox- 
idase  (A2so  = 2.80)  at  a concentration  of  2.0  mg/ml in  PBS was added. 30 ~l  of  neutralized  ~251  (300 
~Ci)  in  PBS  was  next  added  to  each  tube.  The  iedination  reaction,  initiated  by  the  addition  of  10  ftl 
of  0.03% H~O2 in PBS (diluted  from a 30% stock  solution  just  before  use)  was carried  out at  30 -+- 
1°C.  Unless  otherwise stated  the  reactions  were terminated  after  5  rain  by the addition  of  2 ml of 
cold  PBS containing 5 mM  KI (PBS-KI). 
After centrifugation  at 140  g for  8  min the  cells  were washed three  times  in  2 ml of  PBS-KI by 
centrifugation  and resuspension.  After  the  second and third  centrifugation  steps  the cell  suspen- 
sions were transferred to new polystyrene tubes. After the final  wash the cell  pellets  were 
suspended in  60/~l  of  PBS for  detergent extraction. 
Solubilization  of  Iodinated Cell  Surface Components.  Cell  surface  components were solubi- 
lized  using  the nonionic detergent  Nonidet  P-40 (NP-40) essentially  as  described  by Vitetta  et  al. 
(21).  To iodinated cell  suspensions (60 /~I)  was added a quantity of  2% (wt/vol)  NP-40 in PBS 
sufficient  to  bring  the NP-40 concentration  to 0.5%. These suspensions were allowed to stand at 
room temperature  for  15  rain.  In  order  to  insure  that  samples  to  be  treated  with  normal  serum and 
antiserum  contained comparable  amounts  of  IssI  label,  the  NP-40  extracts  from  the  several  parallel 
iodinations  were  pooled  into  a i  ml  polyethylene tube.  Nuclei and  cellular  debris  were  removed  by 
centrifugation  in  an  Eppendorf  centrifuge  3200  at  3,200g  for  15  rain.  The  superuate  containing the 
solubilized  iodinated  cell  surface  components  was divided  into  the  appropriate  number of  aliquots 
which were then treated  in  various ways as described  below. 
Trypsinization of the Iodinated Cells.  107 thymocytes were iedinated as described above. The 
incorporation of 125I was terminated by the addition of 10 ~1 of 1 M KI and 1 ml of trypsin (10 ~g/ 
ml) in PBS. Trypsinization was performed at room temperature for 10 min and was terminated by 
the addition of 1 ml of soybean trypsin inhibitor (20 ~g/ml) in PBS (22). Cells were then washed as 
described above. 
Absorption of Antisera.  Aliquots of anti-Ly-3.1 serum (25 ~l) were diluted to 50 ~1 with PBS. 
Each  aliquot was  then mixed  with a  wet cell  pellet containing 6  ×  l0  s thymocytes from the 
appropriate  strain.  After incubation at 4°C  for 1 h  with occasional shaking,  suspensions were 
centrifuged at 3,200 g  for 5 min and the supernates were recovered. 
Absorption with C57BL/6-Ly-2~,Ly-3  ~ thymocytes resulted in removal of all cytotoxic activity 
for Ly-3.1-positive thymocytes. Absorbed antisera were stored frozen at -70°C until use. 
SDS-PAGE.  SDS-PAGE was performed on 5, 10, and 15% (wt/vol) polyacrylamide gels (0.6 × 
11 cm) using a  modification of the method of Weber and Osborn (23).  Immune precipitates were 
suspended in 55 ~1 of a solution containing 0.05 M Tris/C1, pH 8.4, 8 M urea, and 2% SDS. Mouse 
IgG labeled with ~31I using chloramine-T (24) was usually added as an internal molecular weight 
marker.  After  the  addition  of  5  ~1  of  2-mercaptoethanol  and  5  /~1  of  an  0.05%  solution  of 
bromophenol blue,  the  samples were  incubated at  55°C  for  1 h  to  promote  solubilization and 
reduction of the components present in the immune precipitate. Immediately before electrophore- 
sis, the samples were placed  in a  boiling water bath for 2 min. Electrophoresis was generally 
performed at 3 re_A/tube for 15 h  at room temperature. After this period of time the bromophenol 
blue-tracking dye had migrated to a position approximately 8 cm from the origin. Gels were then 
removed from the tubes and frozen at -70°C in 50% glycerol (vol/vol). Gel slices (2 mm in length) 
were placed in tubes and counted using a  Packard Autogamma Scintillation Counter (Packard 
Instrument Co., Inc., Downers Grove, Ill.). 
"Clearing"  ofNP-40 Supernates.  Before precipitation with anti-Ly-3.1 serum, NP-40 extracts 
were preprecipitated  (or  "cleared")  with normal mouse serum (NMS) and RAMIG  to  remove 1251- 
labeled  mouse IgG and any other  labeled  material which might be  nonspecifically  included in  an 
immunological  precipitate.  To 80/~l  of  NP-40  extract  containing 6-9 × 10  ~  cpm  was added 25 ~l  of 
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IgG was also added to determine the efficiency of immune precipitation. After incubation at 37°C 
for 30 min, 50 ~l of RAMIG was added, and incubation was continued at 37°C for an additional 30 
min. This quantity of RAMIG had been shown to be optimal for precipitating all of the mouse IgG 
present in 25 ~l of NMS. Samples were then stored at 4°C for 1 h before removal of the precipitates 
by centrifugation. Supernates were cleared a  second time before specific precipitation with anti- 
Ly-3.1 serum was attempted. An NP-40 concentration of 0.5% was maintained throughout by the 
addition of appropriate quantities of 2% (wt/vol) NP-40. 
The precipitates  obtained from clearings and specific precipitation  (see below) were washed 
three  times by centrifugation  and  resuspension  in  1 ml of cold PBS.  Between each wash  the 
suspension was transferred to a  clean glass tube. 
Precipitation of  Ly-3.1 by Indirect Immune Precipitation.  To cleared NP-40 extracts, 25 or 50 ~l 
of anti-Ly-3.1 serum and 5 ~l of ~31I-labeled IgG were added, followed by incubation at 37°C for 30 
min. RAMIG (50 ~1) was added to precipitate all mouse IgG present in the solution. Samples were 
incubated at 37°C for 30 rain and then at 4°C for 12 h. The NP-40 concentration was maintained at 
0.5% as described.  Immune precipitates were washed three times by centrifugation and resus- 
pended in 1 ml of cold PBS as described above. 
Labeling of Surface Galactosyl Residues with NaB 3/-/4.  The procedure employed was similar to 
that of Gahmborg and Hakamori (25). In summary,  107 thymocytes in 0.5 ml of PBS were treated 
with  0.1  ml  of galactose  oxidase  (10  U)  in  PBS  at  22°C  for  2  h.  Cells were  washed  once  by 
centrifugation with 2 ml of PBS, and resuspended in 0.5 ml of PBS. 5 ~l of a solution containing 
NaB3H4  (1 mCi) in 0.1 M NaOH was added, and samples were incubated at room temperature for 
30 min. Cells were then washed twice with 2 ml of PBS and subjected to NP-40 lysis as described 
previously.  Clearing before specific immune precipitation  was as described above, except that 
samples were incubated at 4°C for 12 h after the first clearing and for 6 h after the second clearing. 
Specific immune precipitation was as described previously. 
Gel Filtration  of Mixtures of NP-40 Extracts  and NMS or Anti-Ly-3.1  Serum on Sephadex  G- 
200.  To NP-40 extracts of ~25I-labeled cells were added 50 ~l of anti-Ly-3.1 serum or NMS and a 
small quantity of ~3q-labeled mouse IgG as an internal marker.  Appropriate amounts of 2% (wt/ 
vol) NP-40 in PBS were added to maintain a  concentration of 0.5%.  Solutions were incubated at 
37°C for 30 min to promote the formation of immune complexes. Each solution was then subjected 
to gel filtration at 4°C on a column (0.8  × 24 cm) ofSephadex G-200 in PBS containing BSA (2 mg/ 
ml) and NP-40 (0.5%,  wt/vol). To each eluted fraction (0.2 ml) containing ~25I-labeled macromolecu- 
lar material was added a small quantity of ~zlI-labeled (CBA/H-T6J x  SJL/J)F1 IgG to assess the 
efficiency of the subsequent precipitation.  RAMIG (2 ~l) was then added and the solutions were 
incubated  at  37°C  for  30  min.  GARIG  (30-50  ~l)  was  then  added  in  quantity  sufficient  to 
precipitate all of the IgG in the added RAMIG. Samples were incubated at 37°C for 30 rain and then 
overnight at 4°C. Precipitates were recovered by centrifugation, washed three times with 2 ml of 
cold PBS, and subjected to SDS°PAGE as described above. 
Comparisons  of Experiments  Employing  Different  Thymocytes  and/or  Sera.  Experiments 
which  compare  the  activities of various  antisera  and/or  NMS  were performed  in parallel  on 
identical NP-40 extracts,  and  all procedures  and  reagents employed were otherwise  identical. 
When ~25I-labeled NP-40 extracts of thymocytes from different congenic or unrelated inbred strains 
were compared, iedinations and other procedures were performed in parallel under conditions as 
identical as possible. 
Results 
Indirect Precipitation of Ly-3.1 from NP-40 Extracts of C57BL/6-Ly-2a,Ly-3 a 
Thymocytes.  C57BL/6-Ly-2a,Ly-3 ~ thymocytes  (Ly-3.1  positive)  were  labeled 
with  125I and  NP-40  extracts  were  prepared  as  described  (see  Materials  and 
Methods).  Extracts  were  cleared  twice, anti-Ly-3.1  serum  or NMS  was  added  to 
supernates,  and  immune  complexes  and  uncomplexed  mouse  IgG were  precipi- 
tated  with  RAMIG.  Precipitates  were  dissolved  in SDS  buffer,  reduced  with  2- 
mercaptoethanol,  and  subjected  to PAGE  in 10% gels as described.  As shown  in 
Fig.  1  (panels a  and  b),  specific anti-Ly-3.1  serum  results  in precipitation  of an 480  STRUCTURAL  STUDIES  OF  Ly  ANTIGENS 
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FIG.  1.  The effect of Ly-3 phenotype on the immune precipitation of Ly-3.1 from NP-40 
extracts of iodinated thymocytes. Gel profiles are of reduced immune precipitates electro- 
phoresed on 10% polyacrylamide-SDS gels. Cells: refers to the phenotype of the thymocytes 
employed. Ly-2.1,Ly-3.1-positive thymocytes were obtained from C57BL/6-Ly-2a,Ly-3 a mice 
and  Ly-2.2,Ly-3.2-positive cells from  C57BL/6J  mice.  Immune precipitation  was  by  an 
indirect method with the first serum (25 pl of anti-Ly-3.1 serum [a and b] or NMS [c and d]). 
The precipitating antiserum is 50/~l of RAMIG. NMS refers to normal serum from (CBA/H- 
T6J x  SJL/J)F1 mice. The positions of heavy and light chains from 131I-lableled mouse IgG 
are indicated by H  and L, respectively. Peaks A, C, and D are described in text. 
125I-labeled component of apparent molecular weight between that of immuno- 
globulin H and L chains which is absent from precipitates formed with NMS. 
When the  identical  protocol was followed using  12SI-labeled  Ly-3.1-negative 
C57BL/6J  (Fig.  1,  panels c  and d) or C57BL/6-Ly-2 a thymocytes which differ 
from C57BL/6-Ly-2a,Ly-3 a at both Ly-2 and Ly-3, and at Ly-3 only, respectively, 
no significant  difference was observed between gels of NMS- and  antiserum- 
treated extracts. In contrast, anti-Ly-3.2 serum precipitated from NP-40 extracts 
of C57BL/6J thymocytes a component of apparent molecular weight identical to 
the Ly-3.1-related molecule shown in Fig. la. Moreover, results obtained using 
specific anti-Ly-3.2  serum and NP-40 extracts of C57BL/6-Ly-2a,Ly-3 ~ thymo- 
cytes were identical to those obtained with NMS. 
Indirect  Precipitation  of Ly-3.1  Using  Absorbed  Antisera.  As  a  further 
specificity control,  anti-Ly-3.1 serum was absorbed with a  number of C57BL/6- 
Ly-2a,Ly-3 ~ thymocytes sufficient to remove all  cytotoxic activity for Ly-3.1- 
positive  thymocytes  (see Materials  and  Methods).  Similar  aliquots  were  ab- 
sorbed with  equivalent  numbers  of C57BL/6J  thymocytes  (Ly-3.1  negative). 
Aliquots  of normal  (CBA/H-T6J  ×  SJL/J)FI  serum  were  also absorbed with 
thymocytes of each strain.  Cleared ~2~I-labeled extracts of C57BL/6-Ly-2a,Ly-3 a 
cells  were  then  precipitated  with  each  absorbed  antiserum  and  NMS,  and 
precipitates were subjected to SDS-PAGE on 5% gels (Fig.  2). PAUL  J.  DURDA  AND  PAUL  D.  GOTTLIEB  481 
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FIG.  2.  The effects of absorption  (see Materials and Methods) of anti-Ly-3.1 serum with 
Ly-3.1-positive (C57BL/6-Ly-2",Ly-3") or Ly-3.1-negative (C57BL/6J) thymocytes upon the 
immune precipitation of Ly-3.1 from NP-40 extracts of C57BL/6-Ly-2",Ly-3" thymocytes. 
Designations NMS, H, and L are as in Fig. 1. Reduced samples were electrophoresed on 5% 
polyacrylamide-SDS gels.  Included for comparison in the two bottom panels are the gel 
profiles of immune precipitates resulting from the first and second clearings of the NP-40 
extracts with NMS and RAMIG (25/~l and 50/~l, respectively). Peaks A-D are described in 
text. 
Antiserum absorbed with Ly-3.2-positive C57BL/6J thymocytes resulted in 
polyacrylamide gel patterns virtually identical to those obtained with unab- 
sorbed antiserum (Figs. 2b and 2a, respectively). In contrast, absorption with 
C57BL/6.Ly.2a,Ly.3 a thymocytes drastically reduced the quantity of the major 
Ly-3.1 component detectable by these procedures and resulted in a gel pattern 
indistinguishable from that obtained with NMS (Figs. 2c and 2e, respectively). 
Gels of precipitates made with absorbed NMS were indistinguishable from those 
obtained with unabsorbed normal serum (Figs. 2f, 2g, and 2e). 
SDS-PA GE  of  Precipitates  Obtained  by  Clearing  NP-40  Ex- 
tracts.  Immunological precipitates obtained from clearings of ~25I-labeled NP- 
40 extracts of C57BL/6-Ly-2",Ly-3 ~ thymocytes with NMS and RAMIG were 
subjected to SDS-PAGE as described (Figs. 2d and 2h). It is apparent that a 482  STRUCTURAL  STUDIES  OF  Ly  ANTIGENS 
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FIG.  3.  Sephadex G-200 gel filtration of an NP-40 extract of'25I-labeled C57BL/6-Ly-2a,Ly- 
3 a thymocytes. The extract (100 ~l) was mixed with 50 ~1 of anti-Ly-3.1 serum and 5 ~l 131I- 
labeled mouse IgG and the mixture was incubated for 30 min at 37°C before gel filtration at 
4°C.  The column was developed with PBS containing NP-40  (0.5%) and BSA (2 mg/ml). 
Fractions of 0.2 ml were collected. 
considerable amount of radioactivity is precipitated and is distributed through- 
out the gel including at the position of the Ly-3.1 component. 
Gel Filtration of  NP-40 Extracts Containing NMS or Anti-Ly-3.1 Serum.  In 
order to obviate the need for clearing, we added aliquots of NMS or anti-Ly-3.1 
serum to NP-40 extracts  of '2~I-labeled  C57BL/6-Ly-2a,Ly-3 a thymocytes,  and 
after incubation at 37°C for 30 min, these extracts were subjected to gel filtration 
on columns of Sephadex G-200 as described in the Materials and Methods (Fig. 
3). Immune complexes formed between antibody and macromolecular material 
should  have  molecular  weights  greater  than  that  of uncomplexed  IgG  and 
should be eluted from the column earlier than the bulk of the IgG. Such immune 
complexes could then be precipitated  from individual  column fractions  using 
optimal amounts of RAMIG and GARIG antisera. 
Fractions  from  the  gel  filtrations  of C57BL/6-Ly-2a,Ly-3 a samples  treated 
with NMS or antiserum were subjected to immune precipitation with RAMIG 
and GARIG (Table I).  It is apparent that  a  significantly higher percentage  of 
total 125I-labeled material in each fraction is precipitated in the case of anti-Ly- 
3.1 serum-treated NP-40 extracts than from extracts treated simultaneously and 
in  identical  fashion  with  NMS.  Comparable  fractions  from  gel  filtrations  of 
extracts which received neither NMS nor antiserum yielded results identical to 
those obtained with NMS. When extracts of Ly-3.1-negative C57BL/6J thymo- 
cytes were substituted and everything else was kept the same, no difference was 
observed between NMS- and anti-Ly-3.1 serum-treated samples. Thus the differ- 
ences between NMS- and antiserum-treated samples in Table I appear to be Ly- 
3.1 specific. 
A  small amount of 131I-labeled IgG was added as an internal marker to each 
column  fraction  before precipitation.  The  proportion  of the  total  ':31I-labeled 
material  in  each  fraction  which  appeared  in  the  precipitate  is  taken  as  a 
measure of the  efficiency of precipitation  of mouse IgG in that  fraction.  The 
elution position of uncomplexed mouse IgG in that fraction. The elution position PAUL J.  DURDA AND  PAUL D.  GOTTLIEB  483 
TABLE I 
Immune Precipitation of Gel Filtration Fractions of  A nti-Ly-3.1  Serum- and 
NMS-Treated NP-40 Extracts of x25I-Labeled L y-3.1-Positive  Thymocytes* 
Serum added to NP-40 extract 
Total ~25I in  Percent of  Percent of 
Column  fraction  total  125I  131I-labeled 
fraction  (cpm  ×  precipi-  IgG precip- 
10  -5)  tated  itated 
(CBA/H-T6J × SJL/J) FI normal 
serum (50/~l) 
a  0.04  5.80  76.0 
b  0.19  5.44  76.6 
c  0.59  5.82  75.5 
d  1.41  5.95  71.6 
e  1.71  4.84  75.5 
f  1.53  3.09  61.0 
g  1.14  1.92  55.6 
h  1.15  0.82  44.4 
Anti-Ly-3.1 serum (50/~1)  a  0.03  13.40  78.3 
b  0.28  10.42  74.2 
c  1.13  9.11  68.1 
d  1.94  8.22  68.5 
e  1.94  5.97  75.6 
f  1.44  3.53  58.0 
g  1.18  1.61  44.3 
h  1.13  0.75  34.9 
* NP-40 extracts  of 125I-labeled C57BL/6-Ly-2a,Ly-3  a thymocytes  (Ly-3.1 positive) 
were treated with either NMS or anti-Ly-3.1 serum  at 37°C for 30 min.  Treated 
extracts were then subjected to gel filtration  at 4°C on Sephadex G-200 (see Fig. 3) 
and fractions of 0.2 ml were collected. Fractions a-h from each gel fraction (which 
are comparable to Fig. 3, fractions 17-24) were subjected to immune precipitation as 
described in the Materials  and Methods. A small amount of 131I-labeled mouse IgG 
was added to each fraction before precipitation  as an internal standard to test the 
efficiency Of the precipitation  (see Materials  and Methods and text). 
of uncomplexed mouse IgG in  gel  filtrations  of NMS- and  antiserum-treated 
extracts is indicated by the inhibition of precipitation of ~31I-labeled  IgG seen in 
fractions 6 through 8 from both gel filtrations (Table I). This position is identical 
to that determined by prior standardization of the columns with 131I-labeled IgG. 
Thus when  NMS  or antiserum  is  added  to  extracts  before gel  filtration,  the 
percentage of ~25I-labeled  material  precipitated  is maximal in fractions which 
precede the elution position of uncomplexed IgG. 
Analysis  of  Immune  Precipitates  from  Column  Fractions  by  SDS- 
PAGE.  Immune precipitates  from gel  filtration  fractions  (see Table  I) were 
subjected to SDS-PAGE under reducing conditions as described in the Materials 
and  Methods.  SDS-PAGE profiles of comparable gel  filtration  fractions from 
antiserum-treated  and NMS-treated extracts are presented  in Figs.  4a-d  and 
4e-h,  respectively.  It is  apparent  that the  anti-Ly-3.1 serum-treated  samples 
contain significant quantities of a  radioactive component of apparent molecular 
weight between that of IgG H  and L chains, while NMS-treated samples contain 
only trace amounts of radioactivity in this portion of the gel. Specificity controls 
were performed which were similar to those described for the indirect precipita- 
tion from cleared NP-40 extracts  (see  Figs.  1 and 2).  These  controls included 484  STRUCTURAL STUDIES  OF  Ly  ANTIGENS 
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Fro.  4.  SDS-PAGE (10% gels) of reduced immune precipitates from successive fractions 
obtained by gel filtration on Sephadex G-200 of NP-40 extracts of 125I-labeled C57BL/6-Ly- 
2a,Ly-3" thymocytes. NP-40 extracts were incubated with 50/~l of anti-Ly-3.1 serum (left 
column,  panels a,  b,  c,  and d)  or NMS  (right column,  panels e, f, g,  and h)  before gel 
filtration. The protocol employed for immune precipitation of each fraction is described in 
the Materials and Methods.  The gel filtration profile of the antiserum-treated  extract is 
presented in Fig. 3; the profile of the NMS-treated sample is similar. The correspondence of 
fractions is as follows: panels a and e are equivalent to Fig. 3, fraction 19; b and f to fraction 
20; c andg to fraction 21; and d and h to fraction 22. Designations H, L, and NMS are as in 
Fig.  1 legend. 
iodination of Ly-3.1-negative thymocytes from strains  congenic with C57BL/6- 
Ly-2~,Ly-3 a, and absorption of anti-Ly-3.1  serum with Ly-3.1-positive and Ly- 
3.1-negative thymocytes from C57BL/6J congenic strains. In all cases the results 
were consistent with the Ly-3.1 antigen being composed, at least in part,  of a 
component with an apparent mol wt in the range of 30,000-40,000 daltons. 
Effect of Trypsinization of Cells Upon Specific Precipitation with Anti-Ly-3.1 
Serum.  12~I-labeled  C57BL/6-Ly-2",Ly-3 a thymocytes were  subjected to mild 
proteolysis with trypsin. Anti-Ly-3.1 serum was then added to NP-40 extracts of 
trypsinized  and control  cells and mixtures  were subjected to gel filtration  on 
Sephadex  G-200  as described above.  Comparison  of the  gel filtration  profiles 
indicated  that  trypsinization  led to a  60%  loss of 12~I-labeled  macromolecular 
material  as compared  with the  untreated  control.  Immune  precipitates  from PAUL J.  DURDA AND  PAUL D.  GOTTLIEB  485 
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Fro.  5.  The effect of trypsinization upon the  immune precipitation of Ly-3.1. NP-40 
extracts of trypsinized and untreated l~SI-labeled C57BL/6-Ly-2a,Ly-3  Q  thymocytes  were 
mixed with 50 ~l of anti-Ly-3.1 serum and then subjected to gel filtration on Sephadex G- 
200. Fractions were submitted to immune precipitation as described, and precipitates 
containing maximal amounts of ~2sI were reduced and subjected to SDS-PAGE under 
reducing conditions  on 10% gels. Panel a, control; and panel b, trypsinized.  Designations  H 
and L are in Fig. 1 legend. 
column fractions were prepared and subjected to SDS-PAGE as described, and 
gels of comparable fractions of trypsin-treated and untreated samples are pre- 
sented in Fig. 5. It is apparent that digestion with trypsin resulted in degrada- 
tion or loss from the cell surface of  molecules reactive with anti-Ly-3.1 serum. 
Molecular  Weight  of Ly-3.1.  12SI-labeled material  specifically precipitated 
with anti-Ly-3.1 serum was extracted from polyacrylamide gels and re-electro- 
phoresed under reducing conditions in 5, 10, and 15% pelyacrylamide gels in the 
presence of appropriate protein markers of known molecular weight. The loga- 
rithm of  molecular weight was plotted as a function of  mobility in the gel (23, 26) 
(Fig. 6). From its mobility in 5% polyacrylamide gels, the major Ly-3.1-specific 
component detectable by these procedures has an apparent mol wt of approxi- 
mately 39,800 daltons. As determined in 10 and 15% gels, this component has an 
apparent mol wt of approximately 35,000 daltons. 
Effect of Pronase on the Major Ly-3 J-Specific Component.  The major Ly- 
3.1-specific component was extracted from gels and subjected to digestion with 
pronase  in  order  to  determine  whether  it  was  protein  in  nature.  Whereas 
untreated material was 100% precipitable with 10% TCA, less than 10% of the 
pronase-treated material was precipitable. Thus by the criterion of susceptibil- 
ity to digestion by a  proteolytic enzyme, at least  a  portion  of the  molecule 
bearing the Ly-3.1 antigenic specificity must be a polypeptide. 
Other  l~SI-Labeled Components.  Precipitates from cleared NP-40  extracts 486  STRUCTURAL STUDIES  OF  Ly  ANTIGENS 
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FIG. 6.  Determination of the apparent molecular weight of Ly-3.1. Ly-3.1 extracted from 
SDS-polyacrylamide gels was re-electrophoresed  on 5, 10, and 15% gels in the presence of 
various proteins of known molecular weight. LP, lactoperoxidase  (bovine); H, mouse IgG 
heavy chain; ADH, alcohol dehydrogenase (yeast); L, mouse IgG light chain; myo, myoglo- 
bin (equine skeletal muscle); lyso, lysozyme (egg white); and cyto C, cytochrome C (horse 
heart). Mobility is determined relative to a bromophenol blue dye marker. Panela: (.--1), 
5% gels;  (A--A), 10% gels;  and (0--{}), 15% gels.  Panel b:  (O--O), observed  molecular 
weight of Ly-3.1 (peak C, Figs. la and 2a). 
and from fractions obtained by the gel filtration procedure contain a major '25I- 
labeled component which does not enter 10% gels (e.g., Fig.  la,  peak A) and 
which appears on 5% polyacrylamide gels under reducing conditions to have a 
mol wt of approximately 180,000 daltons (Fig. 2, peak A). Comparable amounts 
of this material are precipitated from thymocyte extracts of all strains employed 
in this study in the presence of NMS or specific antiserum. It appears to become 
associated with any immunological precipitate which forms in its presence, and 
its identity remains unknown. 
It is apparent from Figs. 2 a  and 2 b that besides the major detectable compo- 
nent of Ly-3.1 (peak C), two other '2~I-labeled components (peaks B and D) are 
precipitated from C57BL/6-Ly-2a,Ly-3 ~ NP-40 extracts by anti-Ly-3.1 serum and 
are detectable by SDS-PAGE under reducing conditions. These vary in quantity 
in different experiments, and, as determined on 5% gels, components B and D 
have apparent mol wt of approximately 55,000 and 30,000 daltons, respectively. 
Component D is present on 10% gels as a shoulder on the low molecular weight 
side of the major Ly-3.1-specific component (e.g.,  Fig.  la).  The relevance of 
these minor peaks to Ly-3.1 is not known, since '25I-labeled material is some- 
times present at positions B and/or D of gels containing material precipitated 
with NMS (e.g., Fig. 2e). 
Precipitation of cleared Ly-3.1-positive extracts with NMS usually results in a 
small amount of a  125I-labeled component at the approximate position of the 
major Ly-3.1 component (Fig. 2e ). A similar component is often observed when 
extracts of C57BL/6J  cells (Ly-3.1 negative) are precipitated with anti-Ly-3.1 
serum. When displayed on 10% polyacrylamide gels, the maximum of this NMS- 
precipitated peak is usually displaced at least one gel slice towards the origin 
from the maximum of the major detectable Ly-3.1 component. PAUL  J.  DURDA  AND  PAUL  D.  GOTTLIEB  487 
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Fro.  7".  The effect of Ly-3 phenotype on the immune precipitation of Ly-3.1 from NP-40 
extracts of thymocytes labeled with 3H using galactose oxidase and NaB3H4 (see Materials 
and Methods).  Immune precipitation  was  as described above,  and SDS-PAGE  was per- 
formed under reducing conditions in 5% gels. Left column treated with anti-Ly-3.1 serum; 
right column treated with NMS. Cells: refers to the phenotype of the thymocytes employed 
as described in Fig. 1 legend. Designations H, L, and NMS are as above. Peaks A-D are as 
described in text. 
Precipitation of Ly-3.1 Labeled using Galactose  Oxidase and NaB3H4  .  Cell 
surface-associated galactose residues of C57BL/6-Ly-2a,Ly-3  a thymocytes were 
labeled using galactose oxidase and NaB3H4 as described in the Materials and 
Methods. NP-40 extracts were cleared, precipitated with either NMS or anti-Ly- 
3.1  serum, and subjected to SDS-PAGE on 5% gels under reducing conditions 
(Fig.  7). In agreement with the 125I studies, a  major Ly-3.1-specific component 
was observed with an apparent mol wt of 35,000 daltons. Thus it appears that 
this major Ly-3.1 component is a glycoprotein containing galactose residues. 3H- 
labeled components were also observed at positions B and D in the gel as well as 
in the region corresponding to a mol wt of 180,000 daltons (peak A), suggesting 
that these components are also glycoproteins. Galactose oxidase plus NaB3H4 
labeling yielded higher D/B and D/C peak height ratios than enzymatic iodina- 
tion (compare Figs. 7a and 2a ), suggesting that component D is more readily 
labeled by the former method. 
Specific Immune Precipitation ofLy-2.1.  NP-40 extracts of ~25I-labeled Ly- 
2. l-positive and Ly-2. l-negative thymocytes were treated with NMS or anti-Ly- 
2.1  serum and precipitated as described for Ly-3.1.  SDS-PAGE profiles of the 
immune precipitates are presented in Fig. 8. It is apparent that precipitation of 
~2~I-labeled surface components of C57BL/6-Ly-2 ~ thymocytes with anti-Ly-2.1 
serum results in a gel pattern indistinguishable from that obtained after precipi- 
tation of labeled C57BL/6-Ly-2%Ly-3 ~ extracts with anti-Ly-3.1 serum (Figs. 8a 
and 2a, respectively). Treatment of labeled NP-40 extracts of C57BL/6J thymo- 
cytes (Ly-2.1  negative) with anti-Ly-2.1  serum yields a  gel pattern  indistin- 488  STRUCTURAL  STUDIES  OF  Ly  ANTIGENS 
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Fic.  8.  The  effect  of  Ly-2  phenotype  on  immune  precipitation  of  Ly-2.1  from  NP-40 
extracts of iodinated thymocytes. Immune precipitation was as described above, and SDS- 
PAGE was performed under reducing conditions in 5% gels. Left column treated with anti- 
Ly-2.1 serum; and right column treated with NMS. Cells, refers to phenotype of thymocytes 
employed: Ly-2.1,Ly-3.2-positive  thymocytes were obtained from C57BL/6-Ly-2  a mice, and 
Ly-2.2,Ly-3.2-positive  cells from C57BL/6J mice. Designations NMS, H, and L are as in Fig. 
1 legend. 
guishable from that obtained with NMS (Figs. 8 b and 8 d). Thus the thymocyte 
surface component bearing the Ly-2.1 antigenic specificity appears to show the 
same labeling pattern and molecular weight species as the molecule bearing Ly- 
3.1. 
Discussion 
The use of alloantisera as indicators of cell surface polymorphisms in inbred 
mice has led to the  identification  and  genetic mapping  of a  large  number  of 
murine cell surface antigens (27-29). Antigens which are represented on widely 
varying  cell  types  are  generally  assumed  to  play  some  general  role  in  the 
interaction  or maintenance  of cellular  function,  while those  surface  antigens 
represented  on more restricted cell populations  (i.e.,  differentiation  antigens) 
are thought to be involved in the peculiar origins and/or properties of those cell 
types (29). 
The relative ease in obtaining lymphocytes and in characterizing their surface 
components by cytotoxic and absorption assays using alloantisera has led to the 
identification of a large number of alloantigens on T and B lymphocytes. While 
the presence of such antigens on lymphocytes of known location or function is 
useful as an identifying characteristic of such cells, determination of the role, if 
any,  of a  surface  molecule in  mediating  that  function  requires  its  chemical 
characterization. 
The  chemical  characterization  of mouse lymphocyte and  other cell surface 
antigens has revealed that a number of such molecules fall into two basic groups PAUL  J.  DURDA  AND  PAUL  D.  GOTTLIEB  489 
composed of polypeptides of characteristic molecular weights. The H-2, T locus, 
and thymus leukemia antigens appear to consist of large glycoprotein subunits 
with mol wt of approximately 45,000 daltons and a small subunit with a mol wt 
of 12,000 daltons which resembles human fl2-microglobulin (12, 15-18). A major 
glycoprotein subunit of mol wt 35,000 marks the second molecular weight class 
of surface antigens which includes the/-region-associated antigens (or Ia anti- 
gens) coded for by genes located within the H-2 complex (13, 14, 30). Allogeneic 
effect factor,  which is released by T  lymphocytes activated by alloantigens, 
appears by gel filtration to be in this molecular weight range (31) and it has been 
demonstrated to bear Ia antigenic determinants (32). In addition, an antigen- 
specific suppressive T-cell factor which contains antigenic specificities deter- 
mined by the K end of the H-2 complex (H-2K, I-A, and/or I-B ) has a mol wt by 
gel filtration of between 35,000 and 60,000 daltons (33). 
The present studies indicate that  the  thymocyte cell  surface  constituents 
which bear the Ly-3.1 and Ly-2.1 alloantigenic determinants each contain a 
glycoprotein of apparent mol wt 35,000 which contains a  galactose-containing 
carbohydrate moiety. This places them in the same molecular weight range as 
the/-region-associated antigens (13, 14, 30-33),  although no other similarity is 
implied by this comparison. The apparent absence of a  polypeptide of mol wt 
22,500  suggests that typical immunoglobulin L chains containing side chains 
susceptible to iodination under the conditions employed are not a constituent of 
the Ly-3.1 antigen.  If the Ly-3.1 thymocyte surface antigen had contained L 
chains,  one might have  concluded that  a  single genetic locus codes for the 
structures of the IB-peptide marker in mouse VL regions and the Ly-3.1 thymo- 
cyte surface antigen. This would have explained the close genetic linkage of 
these traits (10, 11). Both traits might still be governed by the same structural 
genetic locus  if it  is  demonstrated by  peptide mapping and  by  amino acid 
sequence analysis that the Ly-3.1 polypeptide contains a region which is homolo- 
gous to immunoglobulin L-chain V regions. If no such homologies are found, 
there are three other possibilities: (a) Both traits may be controlled by the same 
genetic locus which does not directly code for their structure; (b) a single locus 
may code for the structure of one of the two traits, and that trait may govern the 
other;  and  (c) the two traits may be governed by closely linked but distinct 
genetic loci. 
It is likely that the Ly-3 a and Ly-3 b alleles code for the polypeptide portions of 
the glycoproteins of mol wt 35,000 which bear, respectively, the Ly-3.1 and Ly- 
3.2 antigenic specificities. However, we have not excluded hypothesis (a),  in 
that alleles at the Ly-3 locus might govern expression of glycosylating enzymes 
which have different substrate specificities and which generate the polymor- 
phisms observed in a fashion analogous to the human blood group substances 
(34). 
If Ly-3.1-positive T cells were needed to stimulate the synthesis of IB-positive 
L chains, then absence of this determinant might result in a IB-negative pheno- 
type.  It  is  unlikely that  such  stimulation  is  by  conventional T-cell  helper 
activity, since Cantor and Boyse have demonstrated using C57BL/6 mice that 
helper T cells are Ly-3.2 negative (7), and it is likely that helper T cells of inbred 
strains bearing the Ly-3 a allele are Ly-3.1 negative. Peptide maps of serum Ig L 490  STRUCTURAL  STUDIES  OF  Ly  ANTIGENS 
chains from (AKR x  BALB/c-nu/nu)F3  nude mice of the Ly-2a,Ly-3 a genotype 
prepared by Boyse and Shen (see reference 11) indicated a quantity of IB-positive 
L chains indistinguishable from that of the AKR/J parent. Thus the absence of a 
thymus and a  normal complement of peripheral T cells did not influence the 
frequency of IB-positive L chains in serum IgG, thus eliminating one form of 
hypothesis (b). Moreover, it had previously been demonstrated that IB-positive 
serum IgG is apparently not autoantibody directed towards the Ly-3.1 antigenic 
specificity (10). Thus it appears that the Ly-3 locus probably does not cause the 
appearance of the I~ phenotype, at least not by the mechanism discussed. 
Thus unless structural homology is demonstrated between the polypeptide" 
bearing the Ly-3.1 antigenic specificity and immunoglobulin VL regions, it is 
likely that the Ly-3 thymocyte surface antigen and the IB-peptide marker in 
mouse VL regions are determined by closely linked but distinct genetic loci 
[hypothesis (c)]. 
Treatment of cleared NP-40 extracts of C57BL/6-Ly-2a,Ly-3 '~ thymocytes  with 
anti-Ly-3.1 serum or anti-Ly-2.1 serum followed by RAMIG results in precipita- 
tion of components of identical molecular weight as revealed by SDS-PAGE 
(Figs.  2 and 8). This is true both for 12~I labeling of polypeptides using lactoper- 
oxidase  (Figs.  2  and  8)  and  for 3H  labeling of carbohydrate moieties using 
galactose oxidase and NaB3H4. These antisera precipitated glycoproteins of mol 
wt 35,000 only from NP-40 extracts of thymocytes of C57BL/6 congenic strains 
with Ly phenotypes for which the antisera were specific. Therefore both the Ly- 
2.1 and Ly-3.1 antigenic specificities are present on molecules containing poly- 
peptides of this molecular weight. This similarity in molecular weight and the 
close genetic linkage of the loci governing the Ly-2 and Ly-3 surface antigens 
suggest the possibility that these polypeptides may be homologous in primary 
structure due to evolution from a common precursor gene, as has been suggested 
for immunoglobulin C-regions  (35-37) and  for the H-2D  and H-2K  surface 
antigens (28). 
Studies using the antibody-blocking test have suggested that the Ly-2 and Ly- 
3  antigenic  specificities are  topologically adjacent  on  the  cell  surface,  and 
therefore may be present on the product of a  single gene (2,  5).  Preliminary 
results obtained in our laboratory suggest that extensive precipitation of 125I- 
labeled C57BL/6-Ly-2a,Ly-3 a thymocytes with anti-Ly-3.1 serum and RAMIG 
reduces to zero the amount of 35,000 mol wt component precipitated by subse- 
quent treatment with anti-Ly-2.1 serum and RAMIG. If these results are borne 
out by further experiments of the type described, then we can conclude that the 
polypeptides bearing the Ly-2.1 and Ly-3.1 antigenic specificities are present on 
the same quarternary complex in the NP-40 extract and probably on the thymo- 
cyte surface as well. Studies to determine the molecular weight of the Ly-2 and 
Ly-3 antigens before reduction are in progress. Determination of whether the 
Ly-2.1 and Ly-3.1 antigens are on the same or different polypeptides will very 
likely require peptide mapping studies and amino acid sequence analysis. 
Summary 
Specific anti-Ly sera were employed to precipitate Ly antigens from Nonidet 
P-40 extracts of mouse thymocytes labeled with 125I using lactoperoxidase and PAUL  J.  DURDA  AND  PAUL  D.  GOTTLIEB  491 
with NaB3H4 using galactose oxidase. Thymocytes from mice of the congenic 
strains C57BL/6J (Ly-2.2, Ly-3.2 positive), C57BL/6-Ly-2a,Ly-3 a (Ly-2.1,Ly-3.1 
positive) and  C57BL/6-Ly-2 ~  (Ly-2.1,Ly-3.2-positive) were  used  as  sources  of 
labeled antigens and as immune adsorbants to permit evaluation of  the specific- 
ity of  each anti-Ly serum employed. Results of  sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis (SDS-PAGE) under reducing conditions are consistent 
with the Ly-3.1 antigen containing a glycoprotein subunit with an apparent mol 
wt  of 35,000  daltons.  Specific precipitates obtained  using  anti-Ly-2.1  serum 
yielded SDS-PAGE profiles identical to that obtained with anti-Ly-3.1 serum, 
suggesting that the Ly-2 and Ly-3 antigens have the same molecular weight 
distribution. The relationships of these results to the observed close genetic and 
topological linkage of Ly-2 and Ly-3 and to the genetic linkage of these loci with 
the IB-peptide marker, a  mouse V~-region polymorphism, are discussed. 
Received for publication 8 April 1976. 
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